表紙
市場調查報告書

推動傳染病管理的新技術

Novel Technologies Driving Infectious Disease Management

出版商 Frost & Sullivan 商品編碼 883627
出版日期 內容資訊 英文 45 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
推動傳染病管理的新技術 Novel Technologies Driving Infectious Disease Management
出版日期: 2019年06月26日內容資訊: 英文 45 Pages
簡介

本報告研究轉變傳染病管理的新興診斷技術市場,分析CRISPR型的診斷、免疫檢測法和比色分析法、分子診斷、跨學科技術、成長機會、影響產業的因素等情報。

第1章 摘要整理

第2章 技術概要

  • 即時需求傳染病診斷的推動和阻礙因素
  • 最新及新興傳染病趨勢概要
  • 診斷技術概要
  • 次世代傳染病檢測:全球

第3章 基於CRISPR的快速診斷技術平台

  • 行動連接型的基於CRISPR紙張診斷
  • CRISPR和傳染病之合成生物學結合

第4章 傳染病免疫檢測法、比色分析法最新情報

  • 基於唾液的無症狀性瘧原蟲感染之快速診斷檢測
  • 敗血症的5分鐘內超快速診斷
  • 5-in-1 行動連接型尿液檢測
  • 萊姆病診斷之改良型C6□型ELISA

第5章 即時需求應用的創新聚合□鏈反應技術

  • 10分鐘超快速聚合□鏈反應
  • 病原體識別之可攜式即時PCR平台
  • 血液傳染病之3小時內血液-定序結果、其他

第6章 跨學科診斷平台

  • 基於AI、計算、生物資訊學的診斷平台
  • 傳染病之磁共振、PCR、微流體、NGP基礎之複合型方法
  • 傳染病之表面聲波生物感測器
  • 各種診斷應用之奈米科技、定序、生物資訊學

第7章 成長機會和CTA

  • 成長機會1:理想POC診斷檢測
  • 成長機會2:分子診斷
  • 成長機會3:跨學科行動
  • 成功與成長的策略要求

第8章 主要產業影響因素

目錄
Product Code: D8B4

Upcoming Technologies for Infectious Disease Diagnosis

This research service covers emerging diagnostic technologies that can transform infectious disease management.

  • CRISPR-based diagnostics: CRISPR (clustered regularly interspaced short palindromic repeats) can deliver rapid, portable and accurate diagnostics tests for field applications. This reports deals with two major US-based players developing CRISPR-based point-of-care (POC) rapid diagnostic tests which can be used with or without smartphone for detection of pathogens with improved precision.
  • Immunoassays and colorimetric tests: Immunoassays and colorimetric assays have been the most popular and conventional diagnostic tests used for rapid detection of infections. This research service shed light on some of the most recent advancements in immunoassays and colorimetric-based diagnostic tests for wide variety of infections, sepsis, malaria, Lyme Disease, and Urinary Tract Infections (UTIs).
  • Molecular Diagnostics: Polymerase chain reaction (PCR) has been proved to be the most accurate diagnostic test for genomic biomarker detection, however, its application in field as rapid diagnostic was hindered due to obvious limitations. New advancements in instruments, reagents (dry chemistry) and PCR technology are accelerating pathogen identification. This research service provide introduction to some of the most groundbreaking technologies in molecular diagnosis having great potential in field applications.
  • Multidisciplinary technologies: Developments in microfluidic technology, magnetic resonance, telecommunications, physics (surface acoustic waves) and many more are powering the exiting molecular diagnostics. Certain combinations are portrayed here.

Application of bioinformatics, artificial intelligence, and computational approaches: Next-generation sequencing (NGS) has revolutionized life sciences and healthcare. However, current laboratory-based approaches are still slow and time intensive. Advances in artificial intelligence (AI), computer programming, bioinformatics tools, and cloud technology have enabled generation of sophisticated databases. NGS along with these diverse approaches are transforming pathogen identification and provide more targeted and actionable treatments. Selected novel approached are described in this research service.

Nanopore Technology: New developments in nanotechnology are being applied to miniaturizing the devices for portable and field-based applications. Nanoscale lab-on-chip devices require minimum amount of biological sample. Nano devices are developed for NGS, detection of proteins and other biological analyte and have wide applications from clinical, agriculture to forensic and even space research. This research service summarizes two leading players and their nanopore technologies.

Table of Contents

1.0. Executive Summary

  • 1.1. Research Background: Innovating to Address the Diagnostic Gaps
  • 1.2. Research Scope: Emerging Infection Diagnostic Technologies
  • 1.3. Analysis Framework: Frost & Sullivan Core Value
  • 1.4. Research Methodology: Five Steps Toward Success
  • 1.5. Key Findings of Global Infection Diagnostic Technologies

2. Technology Snapshot

  • 2.1. Drivers and Challenges in Point of Need Infection Diagnostics
  • 2.2. Overview of Recent and Emerging Infection Diagnosis Trends
  • 2.3. Snapshot of Diagnostic Technologies
  • 2.4. Next Generation Infection Diagnostic Technologies, Global, 2019

3. CRISPR-based Rapid Diagnostic Technology Platforms

  • 3.1. Mobile Connected CRISPR-based Paper Diagnostic Tests
  • 3.2. CRISPR Combined With Synthetic Biology for Infection Diagnosis

4. Updated Immuno- and Colorimetric Assays for Infection Diagnosis

  • 4.1. Saliva-based Rapid Diagnosis Test for Subclinical Plasmodium Infections
  • 4.2. Ultra-rapid Diagnosis of Sepsis in 5 Minutes
  • 4.3. 5-in-1 Mobile Connected Urine Testing
  • 4.4. Improved C6 Peptide-based ELISA for Lyme Disease Diagnosis

5. Innovative Polymerase Chain Reaction Technologies for Point of Need Applications

  • 5.1. Ultrafast 10 Minute Polymerase Chain Reaction
  • 5.2. Portable Real-time PCR Platform for Pathogen Identification
  • 5.3. Blood-to-sequencing Results for Blood Infections Within 3 Hours
  • 5.4. Toehold Probe Multiplexed Platform for Infection Diagnosis
  • 5.5. Time Resolved Fluorescence Platform for Routine Pathogen Identification
  • 5.6. Partzymes-based Multiplex PCR for Multiple Pathogens Detection
  • 5.7. CoPrimersTM and RadioProbeTM Improve Specificity Of Diagnostic PCR

6. Multidisciplinary Diagnostic Platforms

  • 6.1. AI, Computational and Bioinformatics-based Diagnostic Platforms
  • 6.2. Magnetic Resonance, PCR, Microfluidics and NGP-based Combination Approaches for Infection Diagnosis
  • 6.3. Surface Acoustic Wave Biosensors for Infection Diagnosis
  • 6.4. Nanotechnology, Sequencing and Bioinformatics for Numerous Diagnostic Applications

7. Growth Opportunities and Companies to Action

  • 7.1. Growth Opportunity 1: Ideal Point of Care Rapid Diagnostic Test
  • 7.2. Growth Opportunity 2: Molecular Diagnostics
  • 7.3. Growth Opportunity 3: Multidisciplinary Approaches
  • 7.4. Strategic Imperatives for Success and Growth

8. Key Industry Influencers

  • 8.1. Industry Interactions-1
  • 8.2. Industry Interactions-2
  • Legal Disclaimer
Back to Top